Gabapentin in Patients at Clinical Risk for Psychosis
Status: | Recruiting |
---|---|
Conditions: | Psychiatric, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 30 |
Updated: | 12/24/2016 |
Start Date: | August 2015 |
End Date: | May 2018 |
Contact: | Gary Brucato, PhD |
Phone: | 646-774-5232 |
The purpose of this study is to test the effects of the drug gabapentin on brain function
thought to be important in the development of schizophrenia. Researchers think that treating
a brain region with gabapentin (the hippocampus) may reduce the risk for developing
schizophrenia.
thought to be important in the development of schizophrenia. Researchers think that treating
a brain region with gabapentin (the hippocampus) may reduce the risk for developing
schizophrenia.
Inclusion Criteria:
1. COPE patient between age of 18-30
2. Capacity to give informed consent
3. Currently using a reliable method of birth control (female) (condom plus spermicide,
diaphragm plus spermicide, IUD, birth control pills, norplant, vasctomy in partner)
Exclusion Criteria:
1. Metal implants in body or a history of metal working, or more than one past MRI scan
with gadolinium
2. Lifetime diagnosis of asthmatic symptoms within the past 3 years or known sensitivity
to contrast agents
3. Lifetime diagnosis of renal failure/disease
4. Acute neurological, neuroendocrine,or medical disorder including renal insufficiency
5. Lifetime diagnosis of hypertension or diabetes
6. Intelligence Quotient (IQ) < 70
7. Acute risk for suicide and/or violence
8. Pregnant, lactating
9. Current abuse of substances (alcohol, cocaine, stimulants, cannabis, opiates,
sedative hypnotics)
10. Current use or anticipated need for antipsychotics or mood stabilizers (all
antipsychotics, also Depakote, lithium, lamotrigine, pregabalin or any med with a
mechanism of action like gabapentin)
11. The Clinical Global Impressions Scale (CGI)-improvement score during study equal to
or greater than 6
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
New York, New York 10032
646-774-5000
Phone: 646-774-5232
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
Click here to add this to my saved trials